Microarray reality checks in the context of a complex disease

Nature Biotechnology

Volumn 22, Issue 5, 2004, Pages 615-621

  Miklos, George L Gabor ^a,b   Maleszka, Ryszard ^c  

^a Secure Genetics   (Australia)

^b Human Genetic Signatures ^*  (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION; GENE SET; MICROARRAYS;

DATA REDUCTION; DISEASE CONTROL; MATHEMATICAL MODELS; MEDICAL APPLICATIONS;

GENETIC ENGINEERING;

DNA;

BYSTANDER EFFECT; COMPLEX FORMATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROBLEM SOLVING; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

COMPUTATIONAL BIOLOGY; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SCHIZOPHRENIA;

EID: 2342624566     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt965     Document Type: Review

References (94)

1. The Chipping Forecast II. Nature Genet. 32 (Suppl.), 465-552 (2002).
2. Taussig, M.J. & Landegren, U. Progress in antibody arrays. Targets 2, 169-176 (2003).
3. Ziauddin, J. & Sabatini, D.M. Microarrays of cells expressing defined cDNAs. Nature 411, 107-110 (2001).
4. Garber, K. Gene expression tests foretell breast cancer's future. Science 303, 1754-1755 (2004).
5. Holzman, T. & Kolker, E. Statistical analysis of global gene expression data: some practical considerations. Curr. Opin. Biotechnol. 15, 52-57 (2004).
6. Wigle, D., Tsao, M. & Jurisica, I. Making sense of lung-cancer gene-expression profiles. Genome Biol. 5, 309 (2004).
7. Andreasen, N.C., Arndt, S., Alliger, R., Miller, D. & Flaum, M. Symptoms of schizophrenia. Methods, meanings and mechanisms. Arch. Gen. Psychiatry 52, 341-351 (1995).
8. Andreasen, N.C. A unitary model of schizophrenia. Bleuler's "fragmented Phrene" as schizencephaly. Arch. Gen. Psychiatry 56, 781-787 (1999).
9. Sedvall, G. & Farde, L. Chemical brain anatomy in schizophrenia. Lancet 346, 743-749 (1995).
10. Harrison, P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593-624 (1999).
11. McCarley, R.W. et al. MRI anatomy of schizophrenia. Biol. Psychiatry 45, 1099-1119 (1999).
12. Andreasen, N.C. Schizophrenia; the fundamental questions. Brain Res. Rev 31, 106-112 (2000).
13. Yolken, R.H., Karlsson, H., Yee, F., Johnston-Wilson, N.L. & Torrey, E.F. Endogenous retroviruses and schizophrenia. Brain Res. Rev. 31, 193-199 (2000).
14. Rothermundt, M., Arolt, V. & Bayer, T.A. Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immun. 15, 319-339 (2001).
15. Karlsson, H. et al. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4634-4639 (2001).
16. Freedman, R. Schizophrenia. N. Engl. J. Med. 349, 1738-1749 (2003).
17. Honey, G.D. et al. The functional neuroanatomy of schizophrenic subsyndromes. Psychol. Med. 33, 1007-1018 (2003).
18. Hakak, Y. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4746-4751 (2001).
19. Mimics, K., Middleton, F.A., Marquez, A., Lewis, D.A. & Levitt, P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67 (2000).
20. Vawter, M.P. et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55, 641-650 (2001).
21. Mimmack, M.L. et al. Gene expression analysis in schizophrenia: reproducible upregulation of several members of the apolipoprotein L family located in a high-susceptibility focus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. USA 99, 4680-4685 (2002).
22. Middleton, F.A., Mimics, K., Pierri, J.N., Lewis, D.A. & Levitt, P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22, 2718-2729 (2002).
23. Pongrac, J., Middleton, F.A., Lewis, D.A., Levitt, P. & Mimics, K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem. Res. 27, 1049-1063 (2002).
24. Guidotti, A. et al. Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 57, 1061-1069 (2000).
25. Popken, G.J., Bunney, W.E., Potkin, S.G. & Jones, E.G. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. USA 97, 9276-9280 (2000).
26. Thompson, P.M. et al. Mapping adolescent brain change reveals dynamic wave of accelerated grey matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. USA 98, 11650-11655 (2001).
27. Rajkowska, G. & Goldman-Rakic, P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach coordinate system. Cereb. Cortex 5, 323-337 (1995).
28. Browning, M.D., Dudek, E.M., Rapier, J.L., Leonard, S. & Freedman, R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol. Psychiatry 34, 529-535 (1993).
29. McGinnis, R.E. et al. Failure to confirm NOTCH4 association with schizophrenia in a large population-based sample from Scotland. Nature Genet. 28, 128-129 (2001).
30. Volk, D.W., Austin, M.C., Pierri, J.N., Sampson, A.R. & Lewis, D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical γ-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57, 237-245 (2000).
31. Bernstein, H.-G.C.A. et al. Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia. Neuroreport 13, 393-396 (2002).
32. Chudin, E. et al. Assessment of the relationship between signal intensities and transcript concentration for Affymetrix GeneChip arrays. Genome Biol. 3, research0005.1z-0005.10 (2001).
33. Churchill, G.A. Fundamentals of experimental design for cDNA microarrays. Nature Genet. 32 suppl. Suppl., 490-495 (2002).
34. Kothapalli, R., Yoder, S.J., Mane, S. & Loughran, T.P. Microarray results: how accurate are they? BMC Bioinformatics 3, 22 (2002).
35. Kuo, W.P. et al. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics 18, 405-412 (2002).
36. Li, J., Pankratz, M. & Johnson, J.A. Differential gene expression patterns revealed by oligonucleatide versus long cDNA arrays. Toxicol. Sci. 69, 383-390 (2002).
37. Barczak, A. et al. Spotted long oligonucleotide arrays for human gene expression analysis. Genome Res. 13, 1775-1785 (2003).
38. Fan, J., Tam, P., Vande Woude, G. & Ren, Y. Normalization and analysis of cDNA microarrays using within-array replications applied to neuroblastoma cell response to a cytokine. Proc. Natl. Acad. Sci. USA 101, 1135-1140 (2004).
39. Mills, J.C. & Gordon, J.I. A new approach for filtering noise from high-density oligonucleotide microarray datasets. Nucleic Acids Res. 29, E72-2 (2001).
40. Li, C. & Wong, W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98, 31-36 (2001).
41. Huntsman, M.M., Tran, B.-V., Potkin, S.G., Bunney, W.E. & Jones, E.G. Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc. Natl. Acad. Sci. USA 95, 15066-15071 (1998).
42. Tkachev, D. et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805 (2003).
43. Kilveri, H.T. A Bayesian approach to variable selection when the number of variables is very large. Institute of Mathematical Statistics, Lecture Notes, Monograph Series. 40, 127-143 (2003).
44. Moler, E.J. et al. Analysis of molecular profile data using generative and discriminative methods. Physiol. Genomics 4, 109-126 (2000).
45. Staudt, L.M. & Brown, P.O. Genomic views of the immune system. Annu. Rev. Immunol. 18, 829-859 (2000).
46. Troyanskaya, O. et al. Missing value estimation methods for DNA microarrays. Bioinformatics 17, 520-525 (2001).
47. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
48. Lemon, W.J., Liyanarachchi, S. & You, M. A high performance test of differential gene expression for oligonucleotide arrays. Genome Biol. 4, R67 (2003).
49. Somorjai, R.L., Dolenko, B. & Baumgartner, R. Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions. Bioinformatics 19, 1484-1491 (2003).
50. Morris, J.S., Yin, G., Baggerly, K.A., Wu, C. & Zhang, L. Pooling information across different studies and oligonucleotide microarray chip types to identify prognostic genes for lung cancer. Methods Microarray Anal. in the press. III, 1-16 (2004).
51. Robb, L., Stephens, R. & Coleman, J. Application of survival and multivariate methods to gene expression data combined from two sources. Methods Microarray Anal. III (2004), in the press.
52. Jung, S.-H., Owzar, K. & George, S. Associating microarray data with a survival end-point. Methods Microarray Anal. III (2004), in the press.
53. Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98, 13790-13795 (2001).
54. Garber, M.E. et al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 98, 13784-13789 (2001).
55. Wigle, D.A. et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res. 62, 3005-3008 (2002).
56. Beer, D.G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Med. 8, 816-824 (2002).
57. Shedden, K. & Cooper, S. Analysis of cell cycle-specific gene expression in human cells as determined by microarrays and double-thymidine block synchronization. Proc. Natl. Acad. Sci. USA 99, 4379-4384 (2002).
58. Gerdes, S.Y. et al. Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J. Bacteriol. 185, 5673-5684 (2003).
59. Birrell, G.W. et al. Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents. Proc. Natl. Acad. Sci. USA 99, 8778-8783 (2002).
60. Ooi, S.L., Shoemaker, D.D. & Boeke, J.D. DNA helicase gene interaction network define using synthetic lethality analyzed by microarray. Nature Genet. 35, 277-286 (2003).
61. Jeong, H., Mason, S.P., Barabasi, A.-L. & Oltvai, Z.N. Lethality and centrality in protein networks. Nature411, 41-42 (2001).
62. Thatcher, J.W., Shaw, J.M. & Dickinson, W.J. Marginal contributions of nonessential genes in yeast. Proc. Natl. Acad. Sci. USA 95, 253-257 (1998).
63. Miklos, G.L.G. & Rubin, G.M. The role of the genome project in determining gene function: insights from model organisms. Cell 86, 521-529 (1996).
64. Zhang, L. et al. Gene expression profiles in normal and cancer cells. Science 276, 1268-1272 (1997).
65. John, B. & Miklos, G.L.G. The Eukaryote Genome in Development and Evolution (Allen & Unwin, London, 1988).
66. Colucci-Guyon, E. et al. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79, 679-694 (1994).
67. Erikson, H.P. A tenascin knockout with a phenotype. Nature Genet. 17, 5-8 (1997).
68. Mills, M.A. et al. Differential expression of the actin-binding proteins, α-actinin-2 and -3 in different species: implications for the evolution of functional redundancy. Hum. Mol. Genet. 10, 1335-1346 (2001).
69. Watkins, S. et al. Analbumenia: three cases resulting from different point mutations in the albumin gene. Proc. Natl. Acad. Sci. USA 91, 9417-9421 (1994).
70. Stock, R.P. & Bialy, H. The sigmoidal curve of cancer. Nature Biotechnol. 21, 13-14 (2003).
71. Kacser, H. & Burns, J.A. The molecular basis of dominance. Genetics 97, 639-666 (1981).
72. Wuensche, A. Basins of attraction in network dynamics. in Modularity in Development and Evolution (eds. Schlosser, G. & Wagner, G.P.) 1-17 (Chicago University Press, Chicago, Illinois, 2004).
73. DeRisi, J.L., Iyer, V.R. & Brown, P.O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680-686 (1997).
74. Arkin, A., Shen, P. & Ross, J. A test case of correlation metric construction of a reaction pathway from measurements. Science 277, 1275-1279 (1997).
75. Dewey, T.G. From microarrays to networks: mining expression time series. Drug Discov Today 7, S170-S175 (2002).
76. Klevecz, R.R., Bolen, J., Forrest, G. & Murray, D.B. A genome-wide oscillation in transcription gates DNA replication and cell cycle. Proc. Natl. Acad. Sci. USA 101, 1200-1205 (2004).
77. Almaas, E., Kovacs, B., Vicsek, T., Oltvai, Z.N. & Barabasi, A.-L. Global organization of metabolic fluses in the bacterium Escherichia coli. Nature 427, 839-843 (2004).
78. Kitano, H. Computational systems biology. Nature 420, 206-210 (2002).
79. Barabasi, A.-L. Linked: The New Science of Networks (Persus Publishing, Cambridge, Massachusetts, USA, 2002).
80. Paulsson, J. Summing up the noise in gene networks. Nature 427, 415-418 (2004).
81. Miklos, G.L.G. & Maleszka, R. Integrating molecular medicine with functional proteomics: realities and expectations. Proteomics 1, 30-41 (2001).
82. Miklos, G.L.G. & Maleszka, R. Protein functions and biological contexts. Proteomics 1, 169-178 (2001).
83. Strohman, R. Maneuvering in the complex path from genotype to phenotype. Science 296, 701-703 (2002).
84. Carney, S.L. Leroy Hood expounds the principles, practice and future of systems biology. Drug Discov. Today 8, 436-438 (2003).
85. Palsson, B. O. In silico biotechnology. Era of reconstruction and interrogation. Curr. Opin. Biotechnol. 15, 50-51 (2004).
86. Miklos, G.L.G. Molecules to cognition: the latter-day lessons of levels, language and lac. Evolutionary overview of brain structure and function in some vertebrates and invertebrates. J. Neurobiol. 24, 842-890 (1993).
87. Famili, I., Forster, J., Nielsen, J. & Palsson, B.O. Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network. Proc. Natl. Acad. Sci. USA 100, 13134-13139 (2003).
88. Liao, J.C. et al. Network component analysis: reconstruction of regulatory signals in biological systems. Proc. Natl. Acad. Sci. USA 100, 15522-15527 (2003).
89. Davidson, E.H., McClay, D.R. & Hood, L. Regulatory gene networks and the properties of the developmental process. Proc. Natl. Acad. Sci. USA 100, 1475-1480 (2003).
90. Herrgard, M.J., Covert, M.W. & Palsson, B.O. Reconciling gene expression data with known genome-scale regulatory network structures. Genome Res. 13, 2423-2434 (2003).
91. Li, J.Z. et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet. 13, 609-616 (2004).
92. Reese, M.G. et al. Genome annotation assessment in Drosophila melanogaster. Genome Res. 10, 483-501 (2000).
93. Jones, L., Ng, S.-K., Ambroise, C. & McLachlan, G. Use of microarray data via model-based classification in the study and prediction of survival from lung cancer. Methods Microarray Anal. III (2004), in the press.
94. Matsuzaki, H. et al. Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res. 14, 414-425 (2004).